61 related articles for article (PubMed ID: 11025591)
1. Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma.
Martini M; D'Alò F; Pierconti F; Ricci R; Capelli A; Leone G; Larocca LM
Haematologica; 2000 Oct; 85(10):1019-23. PubMed ID: 11025591
[TBL] [Abstract][Full Text] [Related]
2. Infrequent bax gene mutations in B-cell lymphomas.
Peng H; Aiello A; Packham G; Isaacson PG; Pan L
J Pathol; 1998 Dec; 186(4):378-82. PubMed ID: 10209486
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the 5' noncoding region of the bcl-6 gene in primary gastric lymphomas.
Go JH; Yang WI; Ree HJ
Mod Pathol; 2001 May; 14(5):410-4. PubMed ID: 11353050
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and molecular analysis of bax, bcl-2 and p53 genes in laryngeal squamous cell carcinomas.
Fracchiolla NS; Capaccio P; Carboni N; Pagliari AV; Neri A; Ronchett D; Pruner G; Silvotti MG; Pignataro L; Buffa R; Broich G
Anticancer Res; 1999; 19(2A):1043-51. PubMed ID: 10368653
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 family of proteins in indolent B-cell non-Hodgkin's lymphoma: study of 116 cases.
Agarwal B; Naresh KN
Am J Hematol; 2002 Aug; 70(4):278-82. PubMed ID: 12210808
[TBL] [Abstract][Full Text] [Related]
7. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study.
Tsamandas AC; Thomopoulos K; Zolota V; Kourelis T; Karatzas T; Ravazoula P; Tepetes K; Petsas T; Karavias D; Karatza C; Bonikos DS; Gogos C
Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329
[TBL] [Abstract][Full Text] [Related]
8. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
Paterson JC; Tedoldi S; Craxton A; Jones M; Hansmann ML; Collins G; Roberton H; Natkunam Y; Pileri S; Campo E; Clark EA; Mason DY; Marafioti T
Haematologica; 2006 Jun; 91(6):772-80. PubMed ID: 16769579
[TBL] [Abstract][Full Text] [Related]
9. Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement.
Bellido M; Capello D; Altés A; Estivill C; Gaidano G; Pujol R; Bordes R; Baiget M; Saglio G; Sierra J; Nomdedéu JF
Haematologica; 2002 Sep; 87(9):908-17. PubMed ID: 12217802
[TBL] [Abstract][Full Text] [Related]
10. Mutation of BAX occurs infrequently in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.
Gaidano G; Vivenza D; Forconi F; Capello D; Gloghini A; Bhatia K; Gutierrez M; Gallicchio M; Avanzi GC; Fassone L; Ariatti C; Buonaiuto D; Cingolani A; Saglio G; Tirelli U; Larocca LM; Dalla-Favera R; Carbone A
Genes Chromosomes Cancer; 2000 Feb; 27(2):177-82. PubMed ID: 10612806
[TBL] [Abstract][Full Text] [Related]
11. BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability.
Brimmell M; Mendiola R; Mangion J; Packham G
Oncogene; 1998 Apr; 16(14):1803-12. PubMed ID: 9583678
[TBL] [Abstract][Full Text] [Related]
12. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H
Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367
[TBL] [Abstract][Full Text] [Related]
13. Frequent mutation of bcl-6 proto-oncogene in high grade, but not low grade, MALT lymphomas of the gastrointestinal tract.
Gaidano G; Capello D; Gloghini A; Fassone L; Vivenza D; Ariatti C; Migliazza A; Saglio G; Carbone A
Haematologica; 1999 Jul; 84(7):582-8. PubMed ID: 10406897
[TBL] [Abstract][Full Text] [Related]
14. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
15. Frequent polymorphic changes but not mutations of TRAIL receptors DR4 and DR5 in mantle cell lymphoma and other B-cell lymphoid neoplasms.
Fernàndez V; Jares P; Beà S; Salaverria I; Guino E; de Sanjosé S; Colomer D; Ott G; Montserrat E; Campo E
Haematologica; 2004 Nov; 89(11):1322-31. PubMed ID: 15531454
[TBL] [Abstract][Full Text] [Related]
16. Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability.
Luke JJ; Van De Wetering CI; Knudson CM
Cell Death Differ; 2003 Jun; 10(6):740-8. PubMed ID: 12761582
[TBL] [Abstract][Full Text] [Related]
17. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.
Martínez-Arribas F; Núñez-Villar MJ; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2003; 23(1B):565-8. PubMed ID: 12680147
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of BCL-2, BCL-X, and BAX in primary central nervous system lymphomas that occur in immunosuppressed patients.
Camilleri-Broët S; Camparo P; Mokhtari K; Hoang-Xuan KH; Martin A; Arborio M; Hauw JJ; Raphaël M
Mod Pathol; 2000 Feb; 13(2):158-65. PubMed ID: 10697273
[TBL] [Abstract][Full Text] [Related]
20. BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32).
De Angeli C; Gandini D; Cuneo A; Moretti S; Bigoni R; Roberti MG; Bardi A; Castoldi GL; del Senno L
Haematologica; 2000 Sep; 85(9):913-21. PubMed ID: 10980628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
